CN1829528A - 包含胃泌素化合物的组合物及其在糖尿病中的应用 - Google Patents

包含胃泌素化合物的组合物及其在糖尿病中的应用 Download PDF

Info

Publication number
CN1829528A
CN1829528A CNA200480022042XA CN200480022042A CN1829528A CN 1829528 A CN1829528 A CN 1829528A CN A200480022042X A CNA200480022042X A CN A200480022042XA CN 200480022042 A CN200480022042 A CN 200480022042A CN 1829528 A CN1829528 A CN 1829528A
Authority
CN
China
Prior art keywords
weeks
compositions
treatment
gastrin
beneficial effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200480022042XA
Other languages
English (en)
Chinese (zh)
Inventor
A·克鲁兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RTP PHARMA Inc
Original Assignee
RTP PHARMA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by RTP PHARMA Inc filed Critical RTP PHARMA Inc
Publication of CN1829528A publication Critical patent/CN1829528A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNA200480022042XA 2003-05-27 2004-05-27 包含胃泌素化合物的组合物及其在糖尿病中的应用 Pending CN1829528A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US03/16660 2003-05-27
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes

Publications (1)

Publication Number Publication Date
CN1829528A true CN1829528A (zh) 2006-09-06

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200480022042XA Pending CN1829528A (zh) 2003-05-27 2004-05-27 包含胃泌素化合物的组合物及其在糖尿病中的应用

Country Status (11)

Country Link
EP (1) EP1648495A2 (https=)
JP (1) JP2007513059A (https=)
CN (1) CN1829528A (https=)
AU (1) AU2004243541A1 (https=)
BR (1) BRPI0410710A (https=)
CA (1) CA2527186A1 (https=)
MX (1) MXPA05012605A (https=)
NO (1) NO20055582L (https=)
PL (1) PL379145A1 (https=)
RU (1) RU2005140518A (https=)
WO (1) WO2004105780A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL156828A0 (en) 2001-01-12 2004-02-08 Waratah Pharmaceuticals Inc Prolonged efficacy of islet neogenesis therapy methods with a gastrin/cck receptor ligand and an egf receptor ligand composition in subjects with preexisting diabetes
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
US7560425B2 (en) 2002-06-07 2009-07-14 Waratah Pharmaceuticals Inc. Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes
US20090202494A1 (en) * 2004-01-30 2009-08-13 Antonio Cruz Combined use of glp-1 agonists and gastrin for regulating blood glucose levels
WO2008106779A1 (en) * 2007-03-02 2008-09-12 Waratah Pharmaceuticals Inc. Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
DE69431212T2 (de) * 1994-01-24 2003-04-10 The General Hospital Corp., Boston Behandlung von diabetes
IL156828A0 (en) * 2001-01-12 2004-02-08 Waratah Pharmaceuticals Inc Prolonged efficacy of islet neogenesis therapy methods with a gastrin/cck receptor ligand and an egf receptor ligand composition in subjects with preexisting diabetes
KR20050074492A (ko) * 2002-10-22 2005-07-18 와라타 파마수티컬즈, 인크. 당뇨병의 치료

Also Published As

Publication number Publication date
EP1648495A2 (en) 2006-04-26
RU2005140518A (ru) 2007-07-10
BRPI0410710A (pt) 2006-06-13
WO2004105780A2 (en) 2004-12-09
AU2004243541A1 (en) 2004-12-09
CA2527186A1 (en) 2004-12-09
JP2007513059A (ja) 2007-05-24
PL379145A1 (pl) 2006-07-24
MXPA05012605A (es) 2006-02-22
NO20055582D0 (no) 2005-11-25
NO20055582L (no) 2006-02-27
WO2004105780A3 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
CN1268391C (zh) 外周给予的glp－1类似物和衍生物在控制肥胖中的用途
US8853159B2 (en) GLP-1 Fusion Peptides
CN1235611A (zh) 应用类胰高血糖素肽－1(glp－1)或类似物消除外科手术后的分解代谢改变
CN1163267C (zh) Glp-1或类似物在中风中的用途
TWI784914B (zh) 包含長效胰島素類似物接合物及長效促胰島素肽接合物之治療糖尿病組成物
CN1501809A (zh) 应用胰高血糖素样促胰岛肽的长期治疗方案
AU2005207870B2 (en) The combined use of GLP-1 agonists and gastrin for regulating blood glucose levels
EP1975176A1 (en) Novel glp-1 fusion peptides, their production and use
CN1129224A (zh) 类胰高血糖素促胰岛素的多肽类似物组合物及其使用方法
TWI781948B (zh) Ｍｇ５３突變體及其製備方法和用途
CN1561224A (zh) 降低与严重疾病相关的死亡率和发病率的方法
JP2009019027A (ja) アミノ末端のアミノ酸が変異したインスリン分泌ペプチド誘導体
CN1229357A (zh) 用生长抑素兴奋剂抑制纤维变性的方法
CN1284876A (zh) 用于控制血液葡萄糖的不溶性组合物
CA2622069A1 (en) Treatment of diabetes related obesity
CN1073976A (zh) 组织选择性胰岛素类似物
US20090117102A1 (en) Methods and compositions using CD3 agonists
HK1080363B (zh) 具有血管活性肠肽的生物学活性的化合物在治疗结节病中的用途
CN101035806A (zh) 新的糊精家族多肽－6（afp－6）类似物和制备和使用它们的方法
CN1829528A (zh) 包含胃泌素化合物的组合物及其在糖尿病中的应用
CN101041693A (zh) 一种新型降血糖多肽及其应用
CN104918954A (zh) N-末端电荷发生变化的胰岛素分泌肽衍生物
CN1056537C (zh) 一种药物制剂
US20130109621A1 (en) Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
AU2024300192A1 (en) Stabilized glp-1 peptides and dual agonist peptides against glp-1r and gipr and methods of use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication